Call Options

7 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$33.53 - $54.79 $5.78 Million - $9.45 Million
172,500 New
172,500 $91,000
Q1 2020

May 08, 2020

SELL
$32.37 - $59.36 $433,757 - $795,424
-13,400 Closed
0 $0
Q4 2019

Feb 11, 2020

BUY
$32.22 - $50.07 $431,748 - $670,938
13,400 New
13,400 $35,000
Q3 2019

Nov 12, 2019

SELL
$33.82 - $48.17 $1.85 Million - $2.64 Million
-54,800 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$35.42 - $45.0 $1.94 Million - $2.47 Million
54,800 New
54,800 $269,000
Q4 2017

Feb 09, 2018

SELL
$15.14 - $20.89 $2.89 Million - $3.99 Million
-191,200 Closed
0 $0
Q3 2017

Nov 08, 2017

BUY
$16.81 - $21.61 $3.21 Million - $4.13 Million
191,200
191,200 $496,000

Others Institutions Holding PTCT

About PTC THERAPEUTICS, INC.


  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $3.31B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track Hap Trading, LLC Portfolio

Follow Hap Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.